Delivery before 37 weeks of pregnancy occurs in 7% of all pregnancies and accounts for as much as 90% of all neonatal morbidity and mortality. Despite improved tocolytic therapy and increased pregnancy surveillance, efforts to reduce the preterm birth rate in the last 20 years have largely been unsuccessful. A lack of knowledge of the events responsible for the onset of normal term labor accounts for our inability to prevent preterm delivery. Oxytocin, however, clearly plays a role in the maintenance if not initiation of both term and preterm labor. Oxytocin receptors in both the myometrium and decidua increase sharply immediately prior to labor. The events responsible for increased oxytocin receptor expression in human pregnancy are unknown. The cause for 70% of all cases of preterm labor is unknown, however, 20% of all cases are the result of intraamniotic infection. Intraamniotic infection results in the production of inflammatory cytokines, including interleukin-1 (IL-1). Interleukin-1 initiates preterm labor through the production of decidual uterotonic prostaglandins. Early infection- induced preterm labor is arrested by the decidual production of anti- inflammatory cytokines, interleukin-1 receptor antagonist (IL-1ra) and transforming growth factor beta (TGF beta) which block the action of IL-1. The role of IL-1 in the regulation of oxytocin receptor has not been investigated. Preliminary data show that IL-1 treatment of human myometrial cells in culture results in a time- and dose-dependent down- regulation of oxytocin receptor binding and a reduction in oxytocin receptor function. The downregulation of prematurely induced uterine oxytocin receptors by IL-1 may be another """"""""protective"""""""" mechanism limiting the preterm labor process in early infection. The objective of this grant proposal is to study the cytokine regulation of the myometrial and decidual oxytocin receptor.
Specific aims will focus on the effect of IL-1 on oxytocin receptor function, including IP3, prostaglandin, and contraction production. Mechanisms responsible for loss of oxytocin receptor binding, including gene transcription, receptor internalization, and degradation will be investigated. The antagonism of IL-1 by IL-lra and TGF beta will be studied. A detailed understanding of the regulation of uterine oxytocin receptors will increase the overall understanding of mechanisms of labor.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HD034373-02
Application #
2674002
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1997-04-01
Project End
2002-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Magee-Women's Hospital of Upmc
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wohler, Jillian E; Smith, Sherry S; Zinn, Kurt R et al. (2009) Gammadelta T cells in EAE: early trafficking events and cytokine requirements. Eur J Immunol 39:1516-26
Friebe-Hoffmann, U; Baston, D M; Hoffmann, T K et al. (2007) The influence of interleukin-1beta on oxytocin signalling in primary cells of human decidua. Regul Pept 142:78-85
Rauk, P N; Friebe-Hoffmann, U; Winebrenner, L D et al. (2001) Interleukin-6 up-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am J Reprod Immunol 45:148-53
Friebe-Hoffmann, U; Chiao, J P; Rauk, P N (2001) Effect of IL-1beta and IL-6 on oxytocin secretion in human uterine smooth muscle cells. Am J Reprod Immunol 46:226-31
Rauk, P N; Chiao, J P (2000) Oxytocin signaling in human myometrium is impaired by prolonged exposure to interleukin-1. Biol Reprod 63:846-50
Rauk, P N; Friebe-Hoffmann, U (2000) Interleukin-1 beta down-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am J Reprod Immunol 43:85-91